Key result
The NHLBI is supporting large-scale genetic and genomic programs to translate knowledge into the prediction, prevention, and preemption of cardiovascular disease.
Design
Review
Authors
Loading...
May accelerate genomic research investment; leaves open clinical translation to CVD prediction and prevention.
This review outlines the NHLBI's strategic emphasis on large-scale cardiovascular genomics and personalized medicine to reduce CVD morbidity and mortality.
O’Donnell et al. (2008) conducted a review in Cardiovascular disease. Large-scale genetic and genomic research was evaluated. The NHLBI is supporting large-scale genetic and genomic programs to translate knowledge into the prediction, prevention, and preemption of cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: